ciprofibrate has been researched along with Dyslipidemias in 4 studies
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To demonstrate the effectiveness and safety of rosuvastatin and ciprofibrate in the treatment of dyslipidemia associated with highly active antiretroviral therapy in patients with HIV." | 7.78 | Rosuvastatin and ciprofibrate in the treatment of dyslipidemia in patients with HIV. ( Cunha, RV; Domingos, H; Domingos, JA; Paniago, AM; Rodrigues, RL; Souza, AS, 2012) |
| "To demonstrate the effectiveness and safety of rosuvastatin and ciprofibrate in the treatment of dyslipidemia associated with highly active antiretroviral therapy in patients with HIV." | 3.78 | Rosuvastatin and ciprofibrate in the treatment of dyslipidemia in patients with HIV. ( Cunha, RV; Domingos, H; Domingos, JA; Paniago, AM; Rodrigues, RL; Souza, AS, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domingos, H | 1 |
| Cunha, RV | 1 |
| Paniago, AM | 1 |
| Souza, AS | 1 |
| Rodrigues, RL | 1 |
| Domingos, JA | 1 |
| Okopień, B | 1 |
| Krysiak, R | 1 |
| Kowalski, J | 1 |
| Madej, A | 1 |
| Belowski, D | 1 |
| Zieliński, M | 1 |
| Herman, ZS | 1 |
| Chironi, G | 1 |
| Simon, A | 1 |
| Gariepy, J | 1 |
| Balice, M | 1 |
| Del-Pino, M | 1 |
| Levenson, J | 1 |
| Rizzo, M | 1 |
| Berneis, K | 1 |
1 review available for ciprofibrate and Dyslipidemias
| Article | Year |
|---|---|
The clinical significance of the size of low-density-lipoproteins and the modulation of subclasses by fibrates.
Topics: Bezafibrate; Clofibric Acid; Dyslipidemias; Fenofibrate; Fibric Acids; Gemfibrozil; Humans; Hypolipi | 2007 |
1 trial available for ciprofibrate and Dyslipidemias
| Article | Year |
|---|---|
Monocyte release of tumor necrosis factor-alpha and interleukin-1beta in primary type IIa and IIb dyslipidemic patients treated with statins or fibrates.
Topics: Adult; Anticholesteremic Agents; C-Reactive Protein; Clofibric Acid; Cytokines; Diabetes Mellitus, T | 2005 |
2 other studies available for ciprofibrate and Dyslipidemias
| Article | Year |
|---|---|
Rosuvastatin and ciprofibrate in the treatment of dyslipidemia in patients with HIV.
Topics: Adult; Antiretroviral Therapy, Highly Active; Cardiovascular Diseases; Cholesterol; Dyslipidemias; F | 2012 |
Differential associations of statin and fibrate treatment with carotid arterial remodeling.
Topics: Adult; Atorvastatin; Bezafibrate; Body Mass Index; Carotid Arteries; Cholesterol, HDL; Clofibric Aci | 2005 |